Efgartigimod Successful in Immune Thrombocytopenia
Efgartigimod significantly improved platelet counts in patients with primary immune...
Read More
Author: Rebecca Shover
Talquetamab Further Investigated in Heavily Pre-Treated MM After Promising Phase 2 Data
Talquetamab demonstrated a favorable safety profile and promising response rates in a heavily...
Read More
Promising Results for Triplet Therapy With Magrolimab in AML
Triplet therapy of azacitidine, venetoclax, and magrolimab was safe as first-line therapy in...
Read More
Lymphoma eBook
Focus on Lymphoma 2022.indd
Read More
AHA 2022 eBook
A curated ebook of recent studies, findings, and thought leader perspectives from AHA 2022.
Read More
Test Your ECTRIMS on NMOSD Knowledge!
A quiz based on the latest NMOSD news and research from ECTRIMS.
Read More
Low-crab Diet
“Too bad it was a typo. I was doing pretty well on the low-crab diet!”
Read More
ASN 2022 eBook
Focus on ASN Chronic Gout 2022.indd
Read More
Dr. MedLaw Q&A: Red Flags Being Director & Referring to Facility
Q: My partner and I (we are both family practitioners) have been offered the opportunity to be...
Read More
Quality of Gout Care Suboptimal Among Aged Care Residents
Almost one-third of residents with gout living in aged care facilities did not receive...
Read More
ECTRIMS NMOSD eBook
ECTRIMS NMOSD 2022a.indd
Read More
ECTRIMS MS eBook
ECTRIMS MS 2022
Read More